Welcome to our dedicated page for Precipio SEC filings (Ticker: PRPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind Precipio鈥檚 cancer-diagnostic breakthroughs without wading through hundreds of technical pages? Start here. Investors often begin with the Precipio quarterly earnings report 10-Q filing to gauge test-volume growth and reimbursement trends, then scan 8-K updates for FDA milestones or new academic partnerships.
Our platform delivers each SEC document the moment it appears on EDGAR and adds AI-powered summaries that translate complex laboratory terminology into plain English. Whether you need Precipio insider trading Form 4 transactions in real time, a concise view of R&D spending hidden deep in the annual report, or a quick comparison of segment revenues across filings, Stock Titan surfaces it instantly.
Use cases:
- Track executive stock sales with the phrase-matched feed 鈥淧recipio executive stock transactions Form 4.鈥�
- Review pipeline progress鈥攐ur AI highlights every HemeScreen or IV-Cell mention across 10-K and 10-Q filings.
- Assess reimbursement risk via keyword tagging in the proxy statement and risk-factor sections.
The coverage is complete: 10-K annual reports, proxy statements on executive compensation, 8-K material events explained, and every Precipio earnings report filing analysis鈥攁ll simplified. Understanding Precipio SEC documents with AI means less time decoding regulatory language and more time making decisions.
Precipio, Inc. reported net sales of $5.65 million for the three months ended June 30, 2025, up from $4.44 million a year earlier, led by service revenue of $5.005 million versus $3.909 million. Gross profit for the quarter was $2.43 million compared with $1.72 million in the prior year. The company recorded net income of $74 thousand in the quarter versus a $1.22 million loss in Q2 2024; for the six months it reported a net loss of $810 thousand compared with a $3.30 million loss a year earlier. A material contributor to quarterly other income was a recorded Employee Retention Credit of approximately $789 thousand.
The balance sheet shows total assets of $18.82 million, cash of $1.13 million and an accumulated deficit of $103.3 million. Management discloses substantial doubt about the company鈥檚 ability to continue as a going concern for the next twelve months absent additional revenue or financing. Material items disclosed include purchase commitments of approximately $2.2 million, a CHC temporary funding balance of about $0.6 million to be repaid through January 2026, and customer concentration with one customer representing ~27% of net sales.
FAQ
What is the current stock price of Precipio (PRPO)?
What is the market cap of Precipio (PRPO)?
